uBriGene, USA  

uBriGene operates in the advanced therapy medicinal products (ATMP) field, providing development and manufacturing support across the full lifecycle of cell and gene therapies. Its capabilities cover process development, GMP manufacturing, quality control testing, regulatory documentation, and translational support from early research through clinical stages.